Report: Cannabis Consumers Spending 25% More During Covid-19 Pandemic
1.3 min readPublished On: March 4th, 2021By HCN News Team
DENVER – Business intelligence from Akerna (Nasdaq: KERN), shows how the Covid-19 pandemic has altered daily lives of North Americans, with cannabis shoppers and patients spending about 25-30% more per purchase and are increasingly purchasing more volume of products per visit.
Over the past year (2020-2021), the average recreational cannabis purchase was $60 – climbing up from $48 in the previous year (2019-2020), with consumers’ basket size growing from an average of 2.25 products to 2.6. For medical purchasing, the average sale size is up to $123 per purchase, up from $100 in the previous year, and basket volume grew from 2.9 items to 3.02.
“This past year was a booming one for cannabis, even amid the economic crisis caused by the Covid-19 pandemic. The biggest change we see in our data is that patients are buying more products per visit, and it’s important for cannabis businesses to take these changes into mind when marketing their products,” said James Ahrendt, Business Intelligence Architect at Akerna. “With flower continuing to be the go-to product, brands should focus on differentiating their flower from the competition as well as education and benefits around other product categories.”
Additional Insights
Cannabis consumer shopping during the Covid-19 pandemic (2/1/2020 – 1/31/2021):
The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.